MABEPA IVS: Financial statements 2020
CVR: 40230157
Source: annual report 2020, Danish Business Authority
01/01/2020 – 31/12/2020
MABEPA IVS (CVR 40230157) has filed annual accounts for 2020. In 2020, the company reported revenue of DKK 262,368 and a net result of DKK 3,220 compared with DKK 2,022 the year before. That is an increase of 371.2% compared with the year before. The profit margin was 1.2%. Equity in the 2020 report amounted to DKK 3,220. The solvency ratio was 100%.
- Revenue
- DKK 262,368
- Gross Profit
- DKK 3,220
- Profit/Loss
- DKK 3,220
- Equity
- DKK 3,220
- Total Assets
- DKK 3,220
Official annual report
How creditworthy is MABEPA IVS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2020
MABEPA IVS has published its annual report for 2019. Revenue came to DKK 55,684, and the net result was DKK 2,022.
About MABEPA IVS
MABEPA IVS was a Danish company of the type Iværksætterselskab based in Glostrup, founded in 2019. The company has been dissolved on 8 September 2021. The company was registered under the industry Konsulentbistand vedrørende informationsteknologi. In 2020, the company reported revenue of DKK 262,368 and a net result of DKK 3,220 compared with DKK 2,022 the year before. Equity in the 2020 report amounted to DKK 3,220.